| Bioactivity | HBV-IN-36 (compound 42) is a HBV inhibior (IC50=2 μM), showing anti-HBV activity with EC50 of 0.58 μM[1]. |
| Target | IC50: 2 μM (HBV); EC50: 0.58 μM (HBV) |
| In Vivo | HBV-IN-36 (compound 42) |
| Name | HBV-IN-36 |
| Formula | C21H18ClFN4O2 |
| Molar Mass | 412.84 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Detta E, et al. Structure-based Design of Novel Hepatitis B Virus Capsid Assembly Modulators. Bioorg Med Chem Lett. 2023 Sep 1;93:129412. |